Viewing Study NCT00016432


Ignite Creation Date: 2025-12-24 @ 9:43 PM
Ignite Modification Date: 2025-12-25 @ 7:24 PM
Study NCT ID: NCT00016432
Status: COMPLETED
Last Update Posted: 2011-04-19
First Post: 2001-05-06
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Exemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or Stage IIIA Breast Cancer Who Have Completed 5 Years of Tamoxifen
Sponsor: NSABP Foundation Inc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module